Why the study?
Does nifedipine alter atrioventricular conduction and refractoriness in the dog heart after beta-adrenergic receptor blockade?
Does nifedipine alter atrioventricular conduction and refractoriness in the dog heart after beta-adrenergic receptor blockade?
In a canine model pretreated with beta-blockers, nifedipine increased heart rate and decreased AV conduction time, demonstrating distinct electrophysiological effects compared to verapamil.
Answers are grounded in this paper and cite their sources.
May indicate distinct AV effects versus verapamil in beta-blocked canine hearts; hypothesis-generating and should not yet change practice.
The effect of nifedipine (BAY 1040), a calcium-antagonistic inhibitor of the electromechanical coupling process was tested on atrioventricular conduction and refractoriness of the dog heart in situ by means of His-bundle electrography and programmed electrical stimulation. The animals were anaesthetized with sodium pentobarbital. As the basic effects of the compound can be altered by release of catecholamines from sympathetic nerves of heart and vessels, the dogs were pretreated with acebutolol, a beta-adrenergic receptor blocking agent, which decreased heart rate and prolonged atrioventricular conduction and refractoriness. Nifedipine 1,6 and particularly 30 microgram/kg body weight increased the heart rate and decreased atrioventricular conduction time during atrial pacing, whereas atrioventricular conduction time during sinus rhythm and atrioventricular refractoriness were only affected by nifedipine 30 microgram/kg. In this respect, nifedipine differs distinctly from another calcium antagonistic compound, verapamil.
No takes yet. Share an insight, caveat, or question.
Amlie et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: